World integrated medicine forum on the regulation of homoeopathic medicinal products: National and global strategies

• Main Authors: Harleen Kaur, Anupriya Chaudhary, Anil Khurana, Todd Hoover, Robbert van Haselen, Raj K Manchanda
• Format: Article
• Language: English
• Published: Wolters Kluwer Medknow Publications 2017-01-01
• Series: Indian Journal of Research in Homoeopathy
• Subjects: Central Council for Research in Homoeopathy; Drug regulations; Export and import of homoeopathic medicines; Good manufacturing practices; Homoeopathic industry; Homoeopathic medicinal products; Homoeopathic pharmacopoeia; World Integrated Medicine Forum; Quality assurance
• Online Access: http://www.ijrh.org/article.asp?issn=0974-7168;year=2017;volume=11;issue=2;spage=123;epage=135;aulast=Kaur

The first World Integrated Medicine Forum on the regulation of homoeopathic medicinal products included 50 delegates from 25 countries to discuss the current state of regulation of homoeopathic medicinal products (HMPs). The stakeholders in attendance included government officials, manufacturers, pharmacopoeia organisations, pharmacists, and healthcare providers worldwide. The Minister of Ayurveda, Yoga, Unani, Siddha and Homoeopathy from India, who is likely the only high ranking national official in the world specifically dedicated to oversight of traditional medicines including Homoeopathy, was the keynote speaker for the meeting. The core presentations delivered information on the country-to-country variance in regulatory requirements for homoeopathic medicine manufacture and marketing. Different speakers addressed the current pharmacopeia structures in various countries, variance in premarket approval process, regulatory frameworks for homoeopathic medicines, labelling requirements, safety requirements, marketing approaches and good manufacturing practices. Debates focused on quality control testing, stability of intermediate stocks, shelf life of finished products, pre-market approval process and labelling and they shed light on regional differences in regulation. A lengthy discussion was held on the potential value of harmonisation of pharmacopoeias, manufacturing standards, safety evaluation and labelling. The group consensus was to meet again to pursue specific topics. Daily summaries of take-away points are provided at the end of each day's talk summaries. Much acclaim was won by the organisers for materialising this unique forum which proved to be an apt platform for rigorous discussions on lesser discussed, but very vital points such as regulations of HMPs, harmonisation of pharmacopeias and linking industry and regulators' sectors for unified efforts for global development of Homoeopathy.